Tuesday, Nov. 3, 2026 A Vik Media Group publication
Mongevity Longevity in Motion
Leer en español
Developing story/Skin

Skin diseases

5 articles · following since Nov. 3, 2026 · last update Nov. 3, 2026

Every update, newest first

  1. In a scarring blistering disease, fewer than half reached remission at every site

    In a study of 77 people with mucous membrane pemphigoid affecting several body sites, published Oct. 28, 2026, in JAMA Dermatology, 45% reached complete remission at every site at once, after a median of 32.0 months. Mouth and eye disease…

  2. Surgery for hidradenitis suppurativa sharply cut pain at 6 months

    A study of eighty-three patients published Oct. 26, 2026, in Dermatologic Surgery found that local surgical removal of hidradenitis suppurativa lesions lowered average pain from 6.9 to 0.9 on a visual pain scale at 6 months.

  3. New US guidelines for hidradenitis suppurativa back four biologics and routine pain checks

    Joint guidelines from the American Academy of Dermatology and the Hidradenitis Suppurativa Foundation, published Oct. 20, 2026, make 37 recommendations, with strong support for four biologic drugs and for checking pain at every visit.

  4. People with hidradenitis suppurativa started GLP-1 drugs earlier and more often

    A Danish nationwide study published Oct. 3, 2026, found that 8.2% of people with hidradenitis suppurativa started a GLP-1 drug vs. 5.7% with psoriasis and 3.2% of controls; HS treatments fell afterward, but similarly in non-users.

  5. Pressing a seed on the ear helped rosacea when added to standard treatment

    In a sham-controlled trial published Oct. 14, 2026, in JAMA Dermatology, 56.9% of people with rosacea who pressed a seed taped on a specific spot of the ear reached clear or almost clear skin at 8 weeks vs. 35.3% with…